US Stock MarketDetailed Quotes
MED Medifast
- 21.760
- +0.770+3.67%
Close Dec 10 16:00 ET
238.01MMarket Cap32.48P/E (TTM)
21.780High20.673Low249.12KVolume21.620Open20.990Pre Close5.34MTurnover2.57%Turnover Ratio2.39P/E (Static)10.94MShares70.58052wk High1.15P/B210.68MFloat Cap17.06952wk Low--Dividend TTM9.68MShs Float298.445Historical High--Div YieldTTM5.28%Amplitude-1.875Historical Low21.420Avg Price1Lot Size
Medifast Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -69.69%9.07M | -69.71%13.07M | -88.63%7.28M | -24.11%147.66M | -79.66%10.52M | -45.97%29.93M | -1.41%43.15M | 46.68%64.06M | 105.80%194.57M | 793.65%51.74M |
| Net income from continuing operations | -95.13%1.13M | -126.93%-8.15M | -79.19%8.32M | -30.75%99.42M | -77.24%6.04M | -36.02%23.13M | -22.58%30.28M | -4.34%39.97M | -12.48%143.57M | -22.06%26.52M |
| Operating gains losses | -366.67%-8K | ---27K | --4K | -44.98%1.17M | --550K | --3K | ---- | ---- | 106,400.00%2.13M | ---- |
| Depreciation and amortization | -6.39%3.19M | -8.94%3.07M | 9.65%3.26M | 19.37%13.11M | 13.51%3.35M | 19.72%3.41M | 23.28%3.37M | 21.69%2.97M | 61.19%10.98M | -2.99%2.95M |
| Deferred tax | 101.68%106K | ---103K | -86.00%112K | 231.06%1.21M | 716.06%6.71M | -260.65%-6.3M | --0 | --800K | 75.13%-924K | 122.13%822K |
| Other non cash items | 10.61%1.13M | 1,018.52%12.81M | -19.07%1.11M | -24.45%4.61M | -20.84%1.08M | -33.42%1.02M | -28.08%1.15M | -15.44%1.37M | 20.30%6.1M | -13.00%1.36M |
| Change In working capital | -80.34%1.18M | -118.85%-984K | -127.60%-5.06M | -6.35%20.28M | -161.79%-9.27M | -56.12%5.99M | 305.27%5.22M | 511.53%18.34M | 124.70%21.65M | 132.85%15.01M |
| -Change in inventory | -104.61%-492K | -76.18%6.67M | -62.12%8.32M | 5.03%64.27M | -86.24%3.64M | -8.77%10.67M | -12.49%28M | 345.94%21.96M | 148.31%61.19M | 152.40%26.42M |
| -Change in prepaid assets | 36.81%5.78M | 62.46%-1.07M | -111.31%-742K | 5,639.18%5.57M | -32.87%-2.38M | 86.62%4.23M | 18.40%-2.84M | 111.23%6.56M | 100.98%97K | 62.61%-1.79M |
| -Change in payables and accrued expense | 39.69%-3.85M | 63.77%-6.77M | -36.24%-12.66M | 5.02%-35.71M | 91.61%-1.35M | -10,728.33%-6.38M | 36.71%-18.68M | -216.22%-9.29M | -169.13%-37.59M | -238.66%-16.13M |
| -Change in other current assets | 89.42%-268K | 114.50%182K | 102.71%24K | -37.57%-4.69M | -100.39%-20K | -573.40%-2.53M | 18.35%-1.26M | 86.63%-887K | 24.90%-3.41M | 546.35%5.13M |
| -Change in other working capital | ---- | ---- | ---- | -766.79%-9.16M | ---- | ---- | ---- | ---- | 245.29%1.37M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -69.69%9.07M | -69.71%13.07M | -88.63%7.28M | -24.11%147.66M | -79.66%10.52M | -45.97%29.93M | -1.41%43.15M | 46.68%64.06M | 105.80%194.57M | 793.65%51.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 96.16%-1.78M | -45.18%-2.53M | -31.21%-2.78M | -434.84%-61.05M | -18.39%-10.73M | -2,527.66%-46.46M | -247.55%-1.74M | -19.90%-2.12M | 60.73%-11.41M | 22.02%-9.06M |
| Net PPE purchase and sale | 17.16%-1.39M | -11.12%-1.94M | 12.96%-1.84M | 61.14%-6.48M | 89.56%-946K | 5.09%-1.68M | 38.59%-1.74M | 29.71%-2.12M | 51.24%-16.68M | 22.02%-9.06M |
| Net investment purchase and sale | 99.12%-392K | ---594K | ---934K | -1,135.96%-54.56M | ---9.79M | ---44.78M | --0 | --0 | 2.37%5.27M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 96.16%-1.78M | -45.18%-2.53M | -31.21%-2.78M | -434.84%-61.05M | -18.39%-10.73M | -2,527.66%-46.46M | -247.55%-1.74M | -19.90%-2.12M | 60.73%-11.41M | 22.02%-9.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 99.98%-3K | 99.89%-20K | 94.24%-1.49M | 60.02%-79.79M | 26.41%-17.91M | 59.75%-18.15M | 82.52%-17.84M | 7.91%-25.9M | -59.50%-199.58M | 22.10%-24.33M |
| Net common stock issuance | 98.18%-2K | -700.00%-16K | 88.05%-817K | 94.56%-6.96M | 99.84%-10K | -340.00%-110K | 100.00%-2K | 40.33%-6.84M | -106.10%-127.96M | 54.93%-6.41M |
| Cash dividends paid | 99.99%-1K | 99.98%-4K | 96.29%-710K | -1.95%-73.02M | -0.31%-17.98M | 0.21%-18.04M | 5.93%-17.83M | -15.02%-19.16M | -12.16%-71.62M | -5.36%-17.92M |
| Proceeds from stock option exercised by employees | --0 | --0 | -65.71%36K | --188K | --83K | --0 | --0 | --105K | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 99.98%-3K | 99.89%-20K | 94.24%-1.49M | 60.02%-79.79M | 26.41%-17.91M | 59.75%-18.15M | 82.52%-17.84M | 7.91%-25.9M | -59.50%-199.58M | 22.10%-24.33M |
| Net cash flow | ||||||||||
| Beginning cash position | -26.72%108.02M | -21.23%97.47M | 7.70%94.44M | -15.83%87.69M | 61.74%112.75M | 141.37%147.41M | 4.87%123.75M | -15.83%87.69M | -36.37%104.18M | -54.88%69.71M |
| Current changes in cash | 121.01%7.29M | -55.37%10.52M | -91.63%3.02M | 141.53%6.82M | -198.75%-18.11M | -506.95%-34.68M | 141.29%23.57M | 161.41%36.05M | 72.47%-16.43M | 136.46%18.34M |
| Effect of exchange rate changes | -84.62%4K | -68.89%28K | 66.67%15K | -7.46%-72K | 45.73%-197K | -78.15%26K | -38.78%90K | -70.00%9K | -159.82%-67K | -1,916.67%-363K |
| End cash Position | 2.27%115.31M | -26.72%108.02M | -21.23%97.47M | 7.70%94.44M | 7.70%94.44M | 61.74%112.75M | 141.37%147.41M | 4.87%123.75M | -15.83%87.69M | -15.83%87.69M |
| Free cash flow | -72.81%7.68M | -73.11%11.13M | -91.22%5.44M | -20.64%141.17M | -77.56%9.58M | -47.32%28.25M | 1.17%41.4M | 52.33%61.94M | 194.83%177.89M | 323.63%42.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data